News & Analysis as of

Belgium › Regulatory Reform › Healthcare

Hogan Lovells

The Belgian Federal Agency for Medicines and Health Products accelerates clinical trial evaluations to boost access to innovative...

Hogan Lovells on

Starting 1 January 2026, the Belgian Federal Agency for Medicines and Health Products (“AFMPS”) will implement accelerated evaluation timelines for initial applications for clinical trials involving medicines for human use....more

1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide